|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
LAB strain Enterococcus faecium isolated from infant feces was found to show desirable probiotic capabilities. The strain was designated as Enterococcus faecium MBTU-P1F1 and gene accession number was obtained as KF745071. The strain did not have plasmid, it was susceptible to Vancomycin and the Minimum Inhibitory Concentration of Ampicillin towards it was examined. Comparison of the growth profile of Enterococcus faecium MBTU-P1F1 with enteric fever pathogens supported early findings which had proved the higher auto aggregating and adhesion ability of the strain than the pathogens. In vivo studies were carried out in balb/c mice to examine the safety of oral administration of the test strain on the health status of animal model. The study further was focused on the safety of the strain for use as human and animal probiotic at phenotypic level.